All Posts By

Dr. Sophia Martinez

Dr. Sophia Martinez is a board-certified endocrinologist with over 15 years of clinical experience in diagnosing and treating various endocrine disorders, including hypogonadism, diabetes, and thyroid diseases. She completed her medical degree from the University of California, San Francisco (UCSF), and her residency in Internal Medicine at Stanford University, followed by a fellowship in Endocrinology at Johns Hopkins Hospital.

Sep 23

Love0

What is Hypogonadism?

By Dr. Sophia Martinez Testosterone Replacement Therapy

Hypogonadism is a medical condition where the body's gonads, either the ovaries or testes, don't function at their optimal capacity. This can lead to reduced secretion of the primary sex hormones: testosterone in…

Jan 21

Love0

5 Benefits of Testosterone Replacement Therapy

By Dr. Sophia Martinez Testosterone Replacement Therapy

Need Testosterone Replacement Therapy? Know the symptoms. As men age, their testosterone levels naturally begin to decline (by approximately 1% every year after the age of 30). Some men with certain medical conditions,…

Jan 21

Love0

10 Benefits of IV Vitamin Therapy

By Dr. Sophia Martinez IV Therapy

What Is IV Vitamin Therapy? Intravenous (IV) vitamin therapy is the administration of nutrients and hydration directly into the bloodstream for immediate absorption by the body. By bypassing the digestive system, IV therapy…

Medical Weight Loss

GPCR-Targeted Obesity Therapies: The Next Frontier Beyond GLP-1 Drugs

Takeaways Emerging GPCR-targeted therapies could offer oral, appetite-modifying weight-loss options with fewer GI side effects. GSBR-1290 shows real human efficacy (~5–7% weight loss) and convenience, while BRP highlights non-incretin, central-acting alternatives in preclinical…

Daxxify’s Role in Hormone-Sensitive Aesthetic Care

Testosterone Replacement Therapy

Daxxify’s Emerging Role in Hormone-Sensitive Aesthetic Medicine

Takeaways Daxxify offers significantly longer-lasting results (6–9 months) compared to traditional neuromodulators, making it especially appealing for patients with hormonal fluctuations. No peer-reviewed research yet exists linking Daxxify’s use to stabilizing estrogen-influenced dermal changes,…

Designer Estrogens 2.0: Tissue-Selective HRT Without Cancer Risk

Testosterone Replacement Therapy

Designer Estrogens 2.0: A New Era in Tissue-Selective Hormone Therapy

Takeaways Designer Estrogens 2.0 offer targeted bone and cognitive benefits while minimizing breast and uterine cancer risks. The 2025 UCSF Phase II trial shows improved bone density and memory with no evidence of…

CHECK OUT OUR BLOG HERE